Speciality Medicines IPO — Listing Performance
Speciality Medicines had a flat debut, closing within 1.53% of its issue price, on tepid subscription of 1.35x.
Speciality Medicines IPO facts & figures
| Issue category | SME |
|---|---|
| Issue open date | 20-Mar-2026 |
| Listing date | 30-Mar-2026 |
| Issue size | ₹27.28 crore |
| Overall subscription | 1.35x |
| Issue price | ₹124 |
| Listing-day close | ₹125.90 (1.53%) |
| Recent market price | ₹195.50 (57.66% vs issue) |
| 52-week range | ₹121.10 – ₹381.20 |
| Identifiers | BSE code: 544738 · ISIN: INE0R0M01014 |
Figures are compiled from public market data and refreshed when our dataset updates. Verify against BSE/NSE records before acting on them.
How the listing went
Speciality Medicines opened for subscription on 20-Mar-2026 as a SME issue raising about ₹27 crore. The shares were priced at ₹124 and made their debut on 30-Mar-2026, closing the first session at ₹125.90 — a listing-day change of 1.53%.
As of our last data refresh the stock trades around ₹195.50, 57.66% above the issue price.
Every IPO in our archive gets this same treatment: real issue data, the actual listing-day result, and where the price stands now — so you can judge how debut hype translated into outcomes. Compare more debuts on the IPO listing-performance archive or check live grey-market sentiment on the GMP board.
Speciality Medicines IPO FAQs
What was the Speciality Medicines IPO listing price?
Speciality Medicines closed at ₹125.90 on its listing day (30-Mar-2026), against an issue price of ₹124 — a listing-day change of 1.53%.
How many times was the Speciality Medicines IPO subscribed?
The issue was subscribed about 1.35 times overall.
Was the Speciality Medicines IPO profitable for allottees?
On listing day, yes: allottees who sold at the closing price made about 1.53% over the issue price. Longer-term outcomes depend on when shares were sold.